BID | 26.47 | ASK | 27.06 | ||
Open | 26.89 | Previous Close | 27.04 | ||
Pre-Market | - | After-Market | - | ||
- -% | - - |
Target Price | 32.00 | Analyst Rating | Moderate Buy 2.00 | |
Potential % | 20.39 | Finscreener Ranking | ★★★★+ 56.64 | |
Insiders Trans % 3/6/12 mo. | -/-/38 | Value Ranking | ★★★★ 56.88 | |
Insiders Value % 3/6/12 mo. | -/-/-2 | Growth Ranking | ★★★★+ 63.22 | |
Insiders Shares Cnt. % 3/6/12 mo. | -/-/-2 | Income Ranking | — - | |
Market Cap | 1.44B | Earnings Rating | Neutral | |
Price Range Ratio 52W % | 87.50 | Earnings Date | 26th May 2021 |
Today's Price Range 26.3926.89 | 52W Range 13.2128.33 | 5 Year PE Ratio Range -3.80741.10 |
Summary:
Buy
Technical Indicators: | Buy |
Moving Averages: | Strong Buy |
Performance | |||
---|---|---|---|
1 Week | 0.45% | ||
1 Month | 0.15% | ||
3 Months | 24.78% | ||
6 Months | 47.92% | ||
1 Year | 98.37% | ||
3 Years | 100.30% | ||
5 Years | 350.67% | ||
10 Years | 1 081.82% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 10.08 | |||
ROE last 12 Months | 14.04 | |||
ROA (5Y Avg) | 2.00 | |||
ROA last 12 Months | 4.70 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | 8.63 | |||
Return on invested Capital Q | 2.04 | |||
Return on invested Capital Y | 8.17 | |||
Assets Turnover | 0.60 | |||
Receivables Turnover | 5.90 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
26.40 | ||||
3.57 | ||||
2.27 | ||||
21.70 | ||||
26.30 | ||||
1.23 | ||||
246.45 | ||||
7.49 | ||||
1.18B | ||||
Forward PE | 23.40 | |||
PEG | 5.28 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
2.80 | ||||
2.90 | ||||
0.43 | ||||
0.79 | ||||
19.80 | ||||
Leverage Ratio | 3.10 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
21.00 | ||||
27.50 | ||||
30.20 | ||||
6.70 | ||||
23.77 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
518.33M | ||||
11.73 | ||||
11.98 | ||||
84.84 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q04 2020 | 0.18 | 0.27 | 50.00 |
Q03 2020 | 0.22 | 0.45 | 104.55 |
Q02 2020 | 0.07 | 0.19 | 171.43 |
Q01 2020 | 0.04 | 0.11 | 175.00 |
Q04 2019 | - | 0.18 | - |
Q03 2019 | 0.14 | 0.14 | 0.00 |
Q02 2019 | 0.05 | 0.09 | 80.00 |
Q01 2019 | 0.08 | 0.00 | -100.00 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
3/2021 QR | 0.22 | -78.22 | Negative |
12/2021 FY | 1.06 | - | - |
12/2022 FY | 1.15 | - | - |
- | - | - | - |
Next Report Date | 26th May 2021 |
Estimated EPS Next Report | 0.22 |
Estimates Count | 1 |
EPS Growth Next 5 Years % | 5.00 |
Volume Overview | |
---|---|
Volume | 4.35K |
Shares Outstanding | 54.59M |
Trades Count | 66 |
Dollar Volume | 1.60M |
Avg. Volume | 77.97K |
Avg. Weekly Volume | 33.64K |
Avg. Monthly Volume | 49.53K |
Avg. Quarterly Volume | 63.56K |
Apollo Medical Holdings Inc. (NASDAQ: AMEH) stock closed at 27.04 per share at the end of the most recent trading day (a -0.33% change compared to the prior day closing price) with a volume of 23.35K shares and market capitalization of 1.44B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 555 people. Apollo Medical Holdings Inc. CEO is Kenneth Sim / Thomas S. Lam.
The one-year performance of Apollo Medical Holdings Inc. stock is 98.37%, while year-to-date (YTD) performance is 48%. AMEH stock has a five-year performance of 350.67%. Its 52-week range is between 13.21 and 28.33, which gives AMEH stock a 52-week price range ratio of 87.50%
Apollo Medical Holdings Inc. currently has a PE ratio of 26.40, a price-to-book (PB) ratio of 3.57, a price-to-sale (PS) ratio of 2.27, a price to cashflow ratio of 21.70, a PEG ratio of 2.32, a ROA of 4.70%, a ROC of 8.63% and a ROE of 14.04%. The company’s profit margin is 23.77%, its EBITDA margin is 30.20%, and its revenue ttm is $518.33 Million , which makes it $11.73 revenue per share.
Of the last four earnings reports from Apollo Medical Holdings Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.22 for the next earnings report. Apollo Medical Holdings Inc.’s next earnings report date is 26th May 2021.
The consensus rating of Wall Street analysts for Apollo Medical Holdings Inc. is Moderate Buy (2), with a target price of $32, which is +20.39% compared to the current price. The earnings rating for Apollo Medical Holdings Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Apollo Medical Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Apollo Medical Holdings Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 14.20, ATR14 : 0.86, CCI20 : 25.09, Chaikin Money Flow : 0.10, MACD : 1.01, Money Flow Index : 61.36, ROC : 1.05, RSI : 60.67, STOCH (14,3) : 42.67, STOCH RSI : 0.73, UO : 57.92, Williams %R : -57.33), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Apollo Medical Holdings Inc. in the last 12-months were: Adrian Vazquez (Sold 86 005 shares of value $1 496 356 ), Albert Young (Sold 0 shares of value $-490 961 ), Brandon Sim (Buy at a value of $749 544), Eric Chin (Buy at a value of $60 792), Kenneth Sim (Buy at a value of $371 072), Kenneth Sim (Sold 0 shares of value $-889 168 ), Mark Fawcett (Option Excercise at a value of $200 000), Thomas S. Lam (Buy at a value of $266 781), Thomas S. Lam (Sold 0 shares of value $-889 140 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Moderate Buy | Moderate Buy | Moderate Buy |
Apollo Medical Holdings Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care in a cost-effective manner. It is focused on physicians providing high-quality medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.
CEO: Kenneth Sim / Thomas S. Lam
Telephone: +1 626 282-0288
Address: 1668 S. Garfield Avenue, Alhambra 91801, CA, US
Number of employees: 555
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE BZX (BATS) real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2021. All market data is provided by Barchart Solutions. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.